Inhibition of the β-lactamase BlaMab by avibactam improves the in vitro and in vivo efficacy of imipenem against mycobacterium abscessus

Lefebvre, A.-L., Le Moigne, V., Bernut, A. orcid.org/0000-0002-1928-8329 et al. (6 more authors) (2017) Inhibition of the β-lactamase BlaMab by avibactam improves the in vitro and in vivo efficacy of imipenem against mycobacterium abscessus. Antimicrobial Agents and Chemotherapy, 61 (4). e02440-16. ISSN 0066-4804

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 American Society for Microbiology. This is an author-produced version of a paper subsequently published in Antimicrobial Agents and Chemotherapy. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: β-lactamase inhibitor; avibactam; Mycobacterium abscessus; cystic fibrosis; imipenem
Dates:
  • Accepted: 20 December 2016
  • Published (online): 17 January 2017
  • Published: April 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 29 Apr 2019 11:30
Last Modified: 29 Apr 2019 11:30
Status: Published
Publisher: American Society for Microbiology
Refereed: Yes
Identification Number: https://doi.org/10.1128/aac.02440-16

Share / Export

Statistics